Q3 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SCYX | New | SCYNEXIS INC | $1,372,000 | – | 311,143 | – | 7.91% | – |
| KDMN | New | KADMON HLDGS INC | $393,000 | – | 100,184 | – | 2.27% | – |
| SCYX | Exit | SCYNEXIS INC | $0 | – | -3,111,436 | – | -9.97% | – |
Q2 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BLPH | New | BELLEROPHON THERAPEUTICS INC | $14,481,000 | – | 1,153,846 | – | 61.82% | – |
| New | EKSO BIONICS HLDGS INC | $6,505,000 | – | 774,400 | – | 27.77% | – | |
| SCYX | New | SCYNEXIS INC | $2,336,000 | – | 3,111,436 | – | 9.97% | – |
| CRVS | New | CORVUS PHARMACEUTICALS INC | $103,000 | – | 38,010 | – | 0.44% | – |
Q4 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CRVS | Exit | CORVUS PHARMACEUTICALS INC | $0 | – | -38,010 | – | -0.25% | – |
| SCYX | Exit | SCYNEXIS INC | $0 | – | -378,811 | – | -0.90% | – |
| TCON | Exit | TRACON PHARMACEUTICALS INC | $0 | – | -4,601,768 | – | -4.59% | – |
| BLPH | Exit | BELLEROPHON THERAPEUTICS INC | $0 | – | -8,298,755 | – | -8.92% | – |
| KDMN | Exit | KADMON HLDGS INC | $0 | – | -3,020,596 | – | -16.79% | – |
| EKSO | Exit | EKSO BIONICS HLDGS INC | $0 | – | -20,534,898 | – | -24.28% | – |
| VRAY | Exit | VIEWRAY INC | $0 | – | -6,842,975 | – | -44.27% | – |
Q3 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CRVS | Sell | CORVUS PHARMACEUTICALS INC | $114,000 | -89.3% | 38,010 | -86.7% | 0.25% | -75.6% |
Q2 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VRAY | New | VIEWRAY INC | $60,287,000 | – | 6,842,975 | – | 59.00% | – |
| EKSO | New | EKSO BIONICS HLDGS INC | $26,079,000 | – | 20,534,898 | – | 25.52% | – |
| KDMN | New | KADMON HLDGS INC | $6,154,000 | – | 3,020,596 | – | 6.02% | – |
| BLPH | New | BELLEROPHON THERAPEUTICS INC | $4,973,000 | – | 8,298,755 | – | 4.87% | – |
| TCON | New | TRACON PHARMACEUTICALS INC | $3,129,000 | – | 4,601,768 | – | 3.06% | – |
| CRVS | New | CORVUS PHARMACEUTICALS INC | $1,065,000 | – | 284,869 | – | 1.04% | – |
| SCYX | New | SCYNEXIS INC | $496,000 | – | 378,811 | – | 0.48% | – |
Q4 2018
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BLPH | Exit | BELLEROPHON THERAPEUTICS INC | $0 | – | -8,298,755 | – | -6.26% | – |
| TCON | Exit | TRACON PHARMACEUTICALS INC | $0 | – | -4,601,768 | – | -6.58% | – |
| KDMN | Exit | KADMON HLDGS INC | $0 | – | -3,822,050 | – | -8.91% | – |
| EKSO | Exit | EKSO BIONICS HLDGS INC | $0 | – | -20,534,898 | – | -33.54% | – |
| VRAY | Exit | VIEWRAY INC | $0 | – | -6,842,975 | – | -44.71% | – |
Q3 2018
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KDMN | Sell | KADMON HLDGS INC | $12,766,000 | -21.9% | 3,822,050 | -6.7% | 8.91% | -27.5% |
Q2 2018
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VRAY | New | VIEWRAY INC | $47,353,000 | – | 6,842,975 | – | 35.62% | – |
| EKSO | New | EKSO BIONICS HLDGS INC | $36,757,000 | – | 20,534,898 | – | 27.65% | – |
| BLPH | New | BELLEROPHON THERAPEUTICS INC | $20,083,000 | – | 8,298,755 | – | 15.10% | – |
| KDMN | New | KADMON HLDGS INC | $16,339,000 | – | 4,095,000 | – | 12.29% | – |
| TCON | New | TRACON PHARMACEUTICALS INC | $12,425,000 | – | 4,601,768 | – | 9.34% | – |